ATE347893T1 - Triazepin-derivate als neurotrope mittel - Google Patents
Triazepin-derivate als neurotrope mittelInfo
- Publication number
- ATE347893T1 ATE347893T1 AT02800474T AT02800474T ATE347893T1 AT E347893 T1 ATE347893 T1 AT E347893T1 AT 02800474 T AT02800474 T AT 02800474T AT 02800474 T AT02800474 T AT 02800474T AT E347893 T1 ATE347893 T1 AT E347893T1
- Authority
- AT
- Austria
- Prior art keywords
- neurotropic agents
- disease
- triazepine
- derivatives
- triazepine derivatives
- Prior art date
Links
- UXIVXGFGVAWZCH-UHFFFAOYSA-N 2h-triazepine Chemical class N1N=CC=CC=N1 UXIVXGFGVAWZCH-UHFFFAOYSA-N 0.000 title 1
- 239000003076 neurotropic agent Substances 0.000 title 1
- 208000024827 Alzheimer disease Diseases 0.000 abstract 1
- 208000006373 Bell palsy Diseases 0.000 abstract 1
- 208000032131 Diabetic Neuropathies Diseases 0.000 abstract 1
- 208000018737 Parkinson disease Diseases 0.000 abstract 1
- 208000006011 Stroke Diseases 0.000 abstract 1
- 208000036826 VIIth nerve paralysis Diseases 0.000 abstract 1
- 206010002026 amyotrophic lateral sclerosis Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 201000006417 multiple sclerosis Diseases 0.000 abstract 1
- 230000001537 neural effect Effects 0.000 abstract 1
- 230000000508 neurotrophic effect Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Neurology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US32692701P | 2001-10-04 | 2001-10-04 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE347893T1 true ATE347893T1 (de) | 2007-01-15 |
Family
ID=23274355
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02800474T ATE347893T1 (de) | 2001-10-04 | 2002-10-04 | Triazepin-derivate als neurotrope mittel |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP1446127B1 (enExample) |
| JP (1) | JP2005504823A (enExample) |
| AT (1) | ATE347893T1 (enExample) |
| AU (1) | AU2002334837B2 (enExample) |
| CA (1) | CA2462643A1 (enExample) |
| DE (1) | DE60216807T2 (enExample) |
| ES (1) | ES2278078T3 (enExample) |
| MX (1) | MXPA04003215A (enExample) |
| WO (1) | WO2003028734A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1240691C (zh) * | 2001-12-06 | 2006-02-08 | 中国人民解放军军事医学科学院毒物药物研究所 | 取代五元氮杂环类化合物及其预防和治疗神经退行性疾病的用途 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6204261B1 (en) * | 1995-12-20 | 2001-03-20 | Vertex Pharmaceuticals Incorporated | Inhibitors of interleukin-1β Converting enzyme inhibitors |
| FR1511147A (fr) * | 1966-12-16 | 1968-01-26 | Soc Ind Fab Antibiotiques Sifa | Nouveaux dérivés de la 11 h-dibenzotriazépine-1, 2, 5 et leurs sels, et procédéde préparation |
-
2002
- 2002-10-04 WO PCT/US2002/031679 patent/WO2003028734A1/en not_active Ceased
- 2002-10-04 MX MXPA04003215A patent/MXPA04003215A/es active IP Right Grant
- 2002-10-04 AU AU2002334837A patent/AU2002334837B2/en not_active Ceased
- 2002-10-04 AT AT02800474T patent/ATE347893T1/de not_active IP Right Cessation
- 2002-10-04 CA CA002462643A patent/CA2462643A1/en not_active Abandoned
- 2002-10-04 EP EP02800474A patent/EP1446127B1/en not_active Expired - Lifetime
- 2002-10-04 DE DE60216807T patent/DE60216807T2/de not_active Expired - Lifetime
- 2002-10-04 ES ES02800474T patent/ES2278078T3/es not_active Expired - Lifetime
- 2002-10-04 JP JP2003532066A patent/JP2005504823A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP1446127B1 (en) | 2006-12-13 |
| CA2462643A1 (en) | 2003-04-10 |
| EP1446127A1 (en) | 2004-08-18 |
| MXPA04003215A (es) | 2005-01-25 |
| DE60216807T2 (de) | 2007-10-04 |
| ES2278078T3 (es) | 2007-08-01 |
| JP2005504823A (ja) | 2005-02-17 |
| AU2002334837B2 (en) | 2007-03-15 |
| DE60216807D1 (de) | 2007-01-25 |
| WO2003028734A1 (en) | 2003-04-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA05002420A (es) | Compuestos de tiazol para el tratamiento de trastornos neurodegenerativos. | |
| CA2501799A1 (en) | Pyrazole compounds for treatment of neurodegenerative disorders | |
| BR0214035A (pt) | Composto | |
| NO20042298L (no) | Farmasoytiske preparater og deres anvendelser | |
| ATE385419T1 (de) | Dermatologische und kosmetische zusammensetzungen enthaltend ein furfurylderivat | |
| MY138252A (en) | Azabicyclic-substitud fused-heteroaryl compounds for the treatment of disease | |
| MEP45308A (en) | [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia | |
| BR9909730A (pt) | Dihidropirimidinas | |
| BR0210028A (pt) | Agentes antibacterianos | |
| EA200600971A1 (ru) | Применение замещённых 2 - аминотетралинов для профилактического лечения болезни паркинсона | |
| BR0316723A (pt) | Derivados de anilinopirazol úteis para o tratamento de diabetes | |
| CA2534532A1 (en) | Compounds for the treatment of neurodegenerative disorders | |
| MXPA05012196A (es) | Compuestos de isoxazol e isotiazol para el tratamiento de trastornos neurodegenerativos. | |
| DE602004008658D1 (de) | Behandlung neurodegenerativer krankheiten | |
| DE60024857D1 (de) | Neue verbindungen | |
| DE60308699D1 (en) | 2-phenylamino-4-trifluoromethyl-5-(benzyl- oder pyridin-4-ylmethyl)carbamoylpyrimidin-derivate als selektive cb2 cannabinoid-rezeptor modulatoren | |
| BRPI0509477A (pt) | compostos de sulfonamida para o tratamento de distúrbios neurodegenerativos | |
| ATE294794T1 (de) | N-heterocyclylhydrazide als neurotrophe mittel | |
| DE602004019500D1 (en) | 4-substituirte-5-cyano-1h-pyrimidin-6-(th)iones als als gsk-3-hemmer | |
| ATE347893T1 (de) | Triazepin-derivate als neurotrope mittel | |
| DE50011645D1 (de) | Sphingomyelinase inhibitoren als wirkstoffe mit antiapoptotischer und antiseptischer wirkung | |
| EP1958939A3 (en) | Pyrazole-amine compounds for the treatment of neurodegenerative disorders | |
| ATE421961T1 (de) | Piperidinderivate, verfahren zu deren herstellung und pharmazeutische zusammensetzung zur behandlung von alzheimer-krankheit, die diese derivate enthält | |
| BR0113814A (pt) | Amidas de ácido fenilciclohexanocarboxìlico e sua aplicação | |
| DE602004014115D1 (de) | Neue amidderivate von 2,2,3,3-tetramethylcyclopropancarbonsäure |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |